Genetic determinism and the overprotection of human subjects

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Assessing Genetic Risks: Implications for Health and Social Policy (eds Andrews, L.B., Fullarton, J.E., Holtzman, N.A. & Motulski, A.G.) (National Academy Press, Washington DC, 1994).

  2. 2

    Reilly, P.R., Boshar, M.F. & Holtzman, S.H. Nature Genet. 15, 16–20 (1997).

  3. 3

    NIH Office of Protection from Research Risks Protecting Human Research Subjects: Institutional Review Board Guidebook (US Government Printing Office, Washington DC, 1993).

  4. 4

    Caporaso, N. & Goldstein, A. Pharmacogenetics 5, 59–63 (1995).

  5. 5

    Dyson, F. Am. Scholar 62, 513–525 (1993).

  6. 6

    Centers for Disease Control MMWR Morb. Mortal. Wkly Rep. 46, 1–24 (1997).

  7. 7

    Strohman, R.C. Nature Biotech. 15, 194–200 (1997).

  8. 8

    Lilienfeld, A.M. & Lilienfeld, D.E. Foundations of Epidemiology (Oxford, New York, 1980).

Download references


Criticisms and helpful suggestions on earlier versions of this manuscript were offered by J. Penta, W. Rogan, D. Sandler and C. Weinberg.

Author information

  1. A.J.W. served as chair of the NIEHS Institutional Review Board from 1994-1998, and J.A.T. is currently vice-chair.

    Correspondence to Allen J. Wilcox.

    Rights and permissions

    Reprints and Permissions

    About this article

    Further reading